Hansoh Pharmaceutical Group Company Limited (BKK:HANSOH19)

Thailand · Delayed Price · Currency is THB · Units

5.65

-0.20 (-3.42%)

Last updated: Sep 10, 2026, 4:26 PM ICT

Market Cap	1.00T
Revenue (ttm)	59.79B
Net Income	21.68B
EPS	3.64
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	0.08 (1.42%)
Ex-Dividend Date	Sep 22, 2026

Volume	66,846
Open	5.70
Previous Close	5.85
Day's Range	5.60 - 5.70
52-Week Range	4.76 - 6.70
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 19, 2026

About BKK:HANSOH19

Hansoh Pharmaceutical Group Company Limited, an investment holding company, engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China. The company provides products for therapeutic areas, including anti-infection, central nervous system, oncology, and metabolic and other diseases, as well as autoimmune diseases. Its principal products include Ameile, Hansoh Xinfu, Pulaile, Xintai, Xinmei, Gainuo, Tanneng, and Pulaitan; Hengmu, Hengsen, Oulanning, Ailanning, and Ameining; XINYUE; and ... [Read more]

Industry Pharmaceutical Preparations

Founded 1995

Employees 9,643

Stock Exchange Stock Exchange of Thailand

Ticker Symbol HANSOH19